<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd"
	xmlns:media="http://search.yahoo.com/mrss/"
>

<channel>
	<title>Pharma Exec Blog &#187; People</title>
	<atom:link href="http://blog.pharmexec.com/tag/people/feed/" rel="self" type="application/rss+xml" />
	<link>http://blog.pharmexec.com</link>
	<description>The Business of Pharmaceuticals</description>
	<lastBuildDate>Wed, 08 Feb 2012 16:14:43 +0000</lastBuildDate>
	
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
		<!-- podcast_generator="podPress/8.8" -->
		<copyright>&#xA9;Advanstar Communications </copyright>
		<managingEditor>gkoroneos@advanstar.com (Advanstar Communications)</managingEditor>
		<webMaster>gkoroneos@advanstar.com(Advanstar Communications)</webMaster>
		<category>Pharmceuticals</category>
		<ttl>1440</ttl>
		<itunes:keywords>pharma, pharmaceuticals, life science, business, news, pharmexec, unplugged</itunes:keywords>
		<itunes:subtitle></itunes:subtitle>
		<itunes:summary>The Business of Pharmaceuticals</itunes:summary>
		<itunes:author>Advanstar Communications</itunes:author>
		<itunes:category text="Science &amp; Medicine">
  <itunes:category text="Medicine"/>
</itunes:category>
<itunes:category text="Science &amp; Medicine">
  <itunes:category text="Medicine"/>
</itunes:category>
<itunes:category text="Business">
  <itunes:category text="Management &amp; Marketing"/>
</itunes:category>
		<itunes:owner>
			<itunes:name>Advanstar Communications</itunes:name>
			<itunes:email>gkoroneos@advanstar.com</itunes:email>
		</itunes:owner>
		<itunes:block>No</itunes:block>
		<itunes:explicit>no</itunes:explicit>
		<itunes:image href="http://lifeinabungalo.com/art/pharmaunplugged_300x30.jpg" />
		<image>
			<url>http://lifeinabungalo.com/art/pharmaunplugged_300x30.jpg</url>
			<title>Pharma Exec Blog</title>
			<link>http://blog.pharmexec.com</link>
			<width>144</width>
			<height>144</height>
		</image>
		<item>
		<title>Now in Video, the Prix Galien Winners</title>
		<link>http://blog.pharmexec.com/2008/10/16/now-in-video-the-prix-galien-winners/</link>
		<comments>http://blog.pharmexec.com/2008/10/16/now-in-video-the-prix-galien-winners/#comments</comments>
		<pubDate>Thu, 16 Oct 2008 20:42:11 +0000</pubDate>
		<dc:creator>Patrick Clinton</dc:creator>
				<category><![CDATA[Events]]></category>
		<category><![CDATA[Awards]]></category>
		<category><![CDATA[People]]></category>
		<category><![CDATA[Prix Galien]]></category>
		<category><![CDATA[Video]]></category>

		<guid isPermaLink="false">http://blog.pharmexec.com/?p=323</guid>
		<description><![CDATA[
At the Prix Galien awards ceremony last month, I had the opportunity to interview the winners on camera. We&#8217;ve just posted edited versions of the interviews here. Inspiring stories, remarkable people (and some great-looking tuxes). Enjoy.
]]></description>
			<content:encoded><![CDATA[<p style="text-align: center;"><img class="size-medium wp-image-328 aligncenter" title="Prix Galien" src="http://blog.pharmexec.com/wp-content/uploads/picture-9.png" alt="" /></p>
<p style="text-align: left;">At the Prix Galien awards ceremony last month, I had the opportunity to interview the winners on camera. We&#8217;ve just posted edited versions of the interviews <a href="http://pharmexec.findpharma.com/pharmexec/cathome/catHome15.jsp" target="_blank">here</a>. Inspiring stories, remarkable people (and some great-looking tuxes). Enjoy.</p>
]]></content:encoded>
			<wfw:commentRss>http://blog.pharmexec.com/2008/10/16/now-in-video-the-prix-galien-winners/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>The Triple P</title>
		<link>http://blog.pharmexec.com/2008/10/14/the-triple-p/</link>
		<comments>http://blog.pharmexec.com/2008/10/14/the-triple-p/#comments</comments>
		<pubDate>Tue, 14 Oct 2008 17:38:02 +0000</pubDate>
		<dc:creator>Brittany Agro</dc:creator>
				<category><![CDATA[Advertising]]></category>
		<category><![CDATA[Ad Age]]></category>
		<category><![CDATA[budgets]]></category>
		<category><![CDATA[Marketing]]></category>
		<category><![CDATA[People]]></category>

		<guid isPermaLink="false">http://blog.pharmexec.com/?p=311</guid>
		<description><![CDATA[Pharma snagged five out of 30 spots designated for the marketing elite on Ad Age&#8217;s Power Players 2008 list. Each individual represents a company that is making milestones in terms of signature accomplishments and advertising spending. Let&#8217;s take a closer look:
#5 Brian Perkins, vice president, corporate affairs
Johnson &#38; Johnson
Ad Budget: $2.41 billion
Key attributes: company&#8217;s sponsorship [...]]]></description>
			<content:encoded><![CDATA[<p>Pharma snagged five out of 30 spots designated for the marketing elite on Ad Age&#8217;s <a href="http://adage.com/article?article_id=131580">Power Players 2008</a> list. Each individual represents a company that is making milestones in terms of signature accomplishments and advertising spending. Let&#8217;s take a closer look:</p>
<blockquote><p>#<strong>5 Brian Perkins</strong>, vice president, corporate affairs<br />
<strong>Johnson &amp; Johnson</strong><br />
Ad Budget: $2.41 billion<br />
Key attributes: company&#8217;s sponsorship of the Beijing Olympics; conversion of Pfizer allergy drug Zyrtec to OTC; continued innovative marketing endeavors with expansion of its BabyCenter portal</p>
<p><strong>#8 Susan Edwards</strong>, vice president, marketing<br />
<strong>GlaxoSmithKline</strong><br />
Ad Budget: $2.46 billion<br />
Key attributes: consumer business up with diet drug Alli (a $200 million brand); Sensodyne growing at double-digits speed; new CEO Andrew Witty outlines plan for more emphasis on consumer products and less on pharmaceuticals</p>
<p><strong>#21 Ian Read</strong>, president, worldwide pharmaceutical operations<br />
<strong>Pfizer</strong><br />
Ad Budget: $1.25 billion<br />
Key attributes: Lyrica and Sutent both up more than 50 percent in the first half; Viagra sales were up 13 percent in the second quarter despite competition; agreement made to forestall direct generic competition against Lipitor until 2011</p></blockquote>
<blockquote><p><strong>#23 Herb Ehrenthal</strong>, group vice president, global advertising and marketing communications<br />
<strong>Schering-Plough Corp.</strong><br />
Ad Budget: $1.09 billion<br />
Key attributes: strong pipeline of drugs in the making; big acquisition of biotech company Organon; organic sales rose 1.4 percent in second quarter</p>
<p><strong>#24 Bernard Poussot</strong>, CEO<br />
<strong>Wyeth</strong><br />
Ad Budget: $1.08 billion<br />
Key attributes: raised full-year expectations with its second quarter earnings; acquired the Thermacare analgesic-heat-wraps brand from P&amp;G; Thermacare can be coupled with its Advil ibuprofen brand</p></blockquote>
<p>For a more complete list of agencies, see the <a href="http://adage.com/datacenter/article?article_id=106348">100 Leading National Advertisers 2008 database</a> on AdAge.com</p>
]]></content:encoded>
			<wfw:commentRss>http://blog.pharmexec.com/2008/10/14/the-triple-p/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Merck&#039;s Yarno Waves Goodbye</title>
		<link>http://blog.pharmexec.com/2008/07/14/mercks-yarno-waves-goodbye/</link>
		<comments>http://blog.pharmexec.com/2008/07/14/mercks-yarno-waves-goodbye/#comments</comments>
		<pubDate>Mon, 14 Jul 2008 19:07:21 +0000</pubDate>
		<dc:creator>Joanna Breitstein</dc:creator>
				<category><![CDATA[People]]></category>
		<category><![CDATA[CMO]]></category>
		<category><![CDATA[Cozaar]]></category>
		<category><![CDATA[Hyzaar]]></category>
		<category><![CDATA[Merck]]></category>
		<category><![CDATA[Wendy Yarno]]></category>

		<guid isPermaLink="false">http://blog.pharmexec.com/2008/07/14/mercks-yarno-waves-goodbye/</guid>
		<description><![CDATA[After more than 25 years at Merck, Wendy Yarno, the company&#8217;s chief marketing officer, will retire. The announcement of Yarno&#8217;s stepping down was made this morning in an e-mail to Merck employees.
Yarno joined Merck in 1983 as a sales rep, went on to launch Cozaar and Hyzaar, and then eventually was named to oversee marketing [...]]]></description>
			<content:encoded><![CDATA[<p>After more than 25 years at Merck, Wendy Yarno, the company&#8217;s chief marketing officer, will retire. The announcement of Yarno&#8217;s stepping down was made this morning in an e-mail to Merck employees.</p>
<p>Yarno joined Merck in 1983 as a sales rep, went on to launch Cozaar and Hyzaar, and then eventually was named to oversee marketing for Merck&#8217;s human healthcare business. Most recently, she received press for her pivotal role in launching Januvia.</p>
<p>Yarno has been out in front, talking about the importance of Merck&#8217;s transformation and the need to create better alignment among the different functions at the company. But all this alignment suggests that Yarno&#8217;s retirement might have come a bit earlier than expected. A source inside the company reveals that this is just the first of many other changes expected to be announced shortly.</p>
]]></content:encoded>
			<wfw:commentRss>http://blog.pharmexec.com/2008/07/14/mercks-yarno-waves-goodbye/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>

